Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Stopped The study was terminated for business reasons and not due to safety concerns.

Conditions

• Adjunctive Treatment of Major Depressive Disorder

Interventions

• DRUG: Pimavanserin

Sponsor

ACADIA Pharmaceuticals Inc.